We’re excited to see Dental Products Report highlight the BeVigilant™ OraFusion™ System as a powerful advancement in oral cancer detection. The article dives into how our technology leverages salivary biomarkers and AI to deliver real-time results chairside—giving dental professionals a fast, non-invasive way to assess potentially malignant lesions. It also features insights from our CEO, Bill Brodie, on how our system integrates into everyday dental workflows and supports earlier, more confident clinical decisions for conditions like leukoplakia and lichen planus.
Read the full article here.
Biomarker Breakthrough: How the BeVigilant™ OraFusion™ System Enhances Chairside Oral Cancer Detection
EN 
IT 
DE 
TR 
PT 
NL 
FR 
ES